193 related articles for article (PubMed ID: 7479744)
1. Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression.
Orlow SJ; Hearing VJ; Sakai C; Urabe K; Zhou BK; Silvers WK; Mintz B
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10152-6. PubMed ID: 7479744
[TBL] [Abstract][Full Text] [Related]
2. Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases.
Orlow SJ; Silvers WK; Zhou BK; Mintz B
Cancer Res; 1998 Apr; 58(7):1521-3. PubMed ID: 9537258
[TBL] [Abstract][Full Text] [Related]
3. Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: a projected basis for immunotherapy.
Le Fur N; Kelsall SR; Silvers WK; Mintz B
Proc Natl Acad Sci U S A; 1997 May; 94(10):5332-7. PubMed ID: 9144237
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma in transgenic mice.
Bradl M; Klein-Szanto A; Porter S; Mintz B
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):164-8. PubMed ID: 1846036
[TBL] [Abstract][Full Text] [Related]
5. The tyrosinase gene family--interactions of melanogenic proteins to regulate melanogenesis.
Winder A; Kobayashi T; Tsukamoto K; Urabe K; Aroca P; Kameyama K; Hearing VJ
Cell Mol Biol Res; 1994; 40(7-8):613-26. PubMed ID: 7787879
[TBL] [Abstract][Full Text] [Related]
6. Melanocyte culture lines from Tyr-SV40E transgenic mice: models for the molecular genetic evolution of malignant melanoma.
Larue L; Dougherty N; Bradl M; Mintz B
Oncogene; 1993 Mar; 8(3):523-31. PubMed ID: 8382353
[TBL] [Abstract][Full Text] [Related]
7. Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models.
Milling SW; Silvers WK; Sai T; Mintz B
Melanoma Res; 2002 Jun; 12(3):221-30. PubMed ID: 12140378
[TBL] [Abstract][Full Text] [Related]
8. Melanosis and associated tumors in transgenic mice.
Klein-Szanto A; Bradl M; Porter S; Mintz B
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):169-73. PubMed ID: 1846037
[TBL] [Abstract][Full Text] [Related]
9. Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.
Takeuchi H; Kuo C; Morton DL; Wang HJ; Hoon DS
Cancer Res; 2003 Jan; 63(2):441-8. PubMed ID: 12543800
[TBL] [Abstract][Full Text] [Related]
10. Human melanoma cell lines show little relationship between expression of pigmentation genes and pigmentary behaviour in vitro.
Eberle J; Wagner M; MacNeil S
Pigment Cell Res; 1998 Jun; 11(3):134-42. PubMed ID: 9730320
[TBL] [Abstract][Full Text] [Related]
11. Development of cutaneous amelanotic melanoma in the absence of a functional tyrosinase.
Cohen-Solal KA; Reuhl KR; Ryan KB; Roberts KG; Chen S
Pigment Cell Res; 2001 Dec; 14(6):466-74. PubMed ID: 11775059
[TBL] [Abstract][Full Text] [Related]
12. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase.
Tsukamoto K; Jackson IJ; Urabe K; Montague PM; Hearing VJ
EMBO J; 1992 Feb; 11(2):519-26. PubMed ID: 1537333
[TBL] [Abstract][Full Text] [Related]
13. Tyrosinase and related proteins in mammalian pigmentation.
del Marmol V; Beermann F
FEBS Lett; 1996 Mar; 381(3):165-8. PubMed ID: 8601447
[TBL] [Abstract][Full Text] [Related]
14. The pinkeyed-dilution protein and the eumelanin/pheomelanin switch: in support of a unifying hypothesis.
Lamoreux ML; Zhou BK; Rosemblat S; Orlow SJ
Pigment Cell Res; 1995 Oct; 8(5):263-70. PubMed ID: 8789201
[TBL] [Abstract][Full Text] [Related]
15. Progressive appearance of pigmentation in amelanotic melanoma lesions.
Cohen-Solal KA; Crespo-Carbone SM; Namkoong J; Mackason KR; Roberts KG; Reuhl KR; Chen S
Pigment Cell Res; 2002 Aug; 15(4):282-9. PubMed ID: 12100494
[TBL] [Abstract][Full Text] [Related]
16. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
Chi DD; Merchant RE; Rand R; Conrad AJ; Garrison D; Turner R; Morton DL; Hoon DS
Am J Pathol; 1997 Jun; 150(6):2143-52. PubMed ID: 9176405
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of specific tyrosinase mRNAs in mouse melanomas with the c2j gene substituted for the wild-type tyrosinase allele: utilization in design of syngeneic immunotherapy models.
Le Fur N; Silvers WK; Kelsall SR; Mintz B
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7561-5. PubMed ID: 9207131
[TBL] [Abstract][Full Text] [Related]
18. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.
Ackermann J; Frutschi M; Kaloulis K; McKee T; Trumpp A; Beermann F
Cancer Res; 2005 May; 65(10):4005-11. PubMed ID: 15899789
[TBL] [Abstract][Full Text] [Related]
19. Expression of tyrosinase, TRP-1 and TRP-2 in ultraviolet-irradiated human melanomas and melanocytes: TRP-2 protects melanoma cells from ultraviolet B induced apoptosis.
Nishioka E; Funasaka Y; Kondoh H; Chakraborty AK; Mishima Y; Ichihashi M
Melanoma Res; 1999 Oct; 9(5):433-43. PubMed ID: 10596909
[TBL] [Abstract][Full Text] [Related]
20. Fibroblasts co-expressing tyrosinase and the b-protein synthesize both eumelanin and phaeomelanin.
Winder AJ; Odh G; Rosengren E; Rorsman H
Biochim Biophys Acta; 1995 Sep; 1268(3):300-10. PubMed ID: 7548229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
